Literature DB >> 11029337

Risk of tuberculosis infection and tuberculous meningitis after discontinuation of Bacillus Calmette-Guerin in Beijing.

L X Zhang1, D H Tu, G X He, Z Q Ma, N J Nagelkerke, M W Borgdorff, D A Enarson, J F Broekmans.   

Abstract

In Beijing, the notification rate of smear-positive tuberculosis (TB) has been below 20 per 100,000 since 1986, and continues to decline. To accurately measure the risk of TB infection in a population in which the results of tuberculin skin testing were not confounded by vaccination with Bacillus Calmette-Guerin (BCG), BCG vaccination at birth was discontinued from 1988 in Shun-yi County. In 1995, the prevalence of TB infection among 12,836 primary school children aged 6 to 7 yr and without BCG scars was 1.4%, giving an estimated annual risk of infection of 0.19% (95% confidence interval: 0.16 to 0.22%). The prevalence of TB infection in children aged 5 to 9 yr in Beijing in 1950 was 46%. The number of cases of tuberculous meningitis did not increase after discontinuation of BCG. We conclude that discontinuation of BCG had no detectable harmful effects, and that control of TB in Beijing has markedly reduced the prevalence of TB infection since 1950.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11029337     DOI: 10.1164/ajrccm.162.4.9911106

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  6 in total

Review 1.  Does neonatal BCG vaccination protect against tuberculous meningitis?

Authors:  V Walker; G Selby; I Wacogne
Journal:  Arch Dis Child       Date:  2006-09       Impact factor: 3.791

Review 2.  The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guérin (BCG) vaccines: is there a link?

Authors:  F Abebe; G Bjune
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

3.  Protective effect of BCG among children vaccinated under universal immunization programme.

Authors:  V K Chadha; L Suryanarayana; H V Suryanarayan; N Srikantaramu; P Kumar
Journal:  Indian J Pediatr       Date:  2004-12       Impact factor: 1.967

Review 4.  Central nervous system tuberculosis: pathogenesis and clinical aspects.

Authors:  R Bryan Rock; Michael Olin; Cristina A Baker; Thomas W Molitor; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

5.  An evaluation of factors associated with taking and responding positive to the tuberculin skin test in individuals with HIV/AIDS.

Authors:  Líbia C R V Moura; Ricardo A A Ximenes; Heloísa L Ramos; Demócrito B Miranda Filho; Carolina D P Freitas; Rosangela M S Silva; Isabella Coimbra; Joanna d'Arc L Batista; Ulisses R Montarroyos; Maria de Fátima P Militão Albuquerque
Journal:  BMC Public Health       Date:  2011-09-05       Impact factor: 3.295

6.  Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease.

Authors:  Grace H Huynh; Daniel J Klein; Daniel P Chin; Bradley G Wagner; Philip A Eckhoff; Renzhong Liu; Lixia Wang
Journal:  BMC Med       Date:  2015-04-21       Impact factor: 8.775

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.